Ординатура / Офтальмология / Английские материалы / Handbook of Nutrition and Ophthalmology_Semba_2007

197.Green MH, Green JB. Quantitative and conceptual contributions of mathematical modeling to current views on vitamin A metabolism, biochemistry, and nutrition. Adv Food Nutr Res 1996;40:3–24.

198.Ross AC, Zolfaghari R. Regulation of hepatic retinol metabolism: perspectives from studies on vitamin A status. J Nutr 2004;134:269S–275S.

199.Ross AC, Zolfaghari R, Weisz J. Vitamin A: recent advances in the biotransformation, transport, and metabolism of retinoids. Curr Opin Gastroenterol 2001;17:184–192.

200.Folman Y, Russell RM, Tang GW, Wolf G. Rabbits fed on β-carotene have higher serum levels of all- trans retinoic acid than those receiving no β-carotene. Br J Nutr 1989;62:195–201.

201.Napoli JL. Retinoic acid synthesis from β-carotene in vitro. Methods Enzymol 1993;214:193–202.

202.Kanai M, Raz A, Goodman DS. Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest 1968;47:2025–2044.

203.Blaner WS. Retinol-binding protein: the serum transport protein for vitamin A. Endocrine Rev 1989; 10:308–316.

204.de Leenheer AP, Lambert WE, Claeys I. All-trans-retinoic acid: measurement of reference values in human serum by high performance liquid chromatography. J Lipid Res 1982;23:1362–1367.

205.Eckhoff C, Nau H. Identification and quantitation of all-trans- and 13-cis-retinoic acid and 13-cis- 4-oxoretinoic acid in human plasma. J Lipid Res 1990;31:1445–1454.

206.Eckhoff C, Collins MD, Nau H. Human plasma all-trans, 13-cis- and 13-cis-4-oxoretinoic acid profiles during subchronic vitamin A supplementation: comparison to retinol and retinyl ester plasma levels. J Nutr 1991;121:1016–1025.

207.Barua AB, Batres RO, Olson JA. Characterization of retinyl β-glucuronide in human blood. Am J Clin Nutr 1989;50:370–374.

208.Sani BP, Barua AB, Hill DL, Shih TW, Olson JA. Retinoyl β-glucuronide: lack of binding to receptor proteins of retinoic acid as related to biological activity. Biochem Pharmacol 1992;43:919–922.

209.Arnhold T, Tzimas G, Wittfoht W, Plonait S, Nau H. Identification of 9-cis-retinoic acid and 9,13- di-cis-retinoic acid, and 14-hydroxy-4,14-retro-retinol in human plasma after liver consumption. Life Sci 1996;59:PL169–PL177.

210.Noy N. The ionization behavior of retinoic acid in aqueous environments and bound to serum albumin. Biochim Biophys Acta 1992;1106:152–158.

211.Bielsalski HK, Frank J, Beck SC, et al. Biochemical but not clinical vitamin A deficiency results from mutations in the gene for retinol binding protein. Am J Clin Nutr 1999;69:931–936.

212.Green MH, Green JB. Dynamics and control of plasma retinol. In: Blomhoff R (ed). Vitamin A in Health and Disease. New York, Marcel Dekker: 1994; pp. 119–133.

213.Smith FR, Goodman DS, Zaklama MS, Gabr MK, El Maraghy S, Patwardhan VN. Serum vitamin A, retinol-binding protein, and prealbumin concentrations in protein-calorie malnutrition. I. A functional defect in hepatic retinol release. Am J Clin Nutr 1973;26:973–981.

214.Ingenbleek Y, van den Schrieck HG, de Nayer P, de Visscher M. The role of retinol-binding protein in protein-calorie malnutrition. Metabolism 1975;24:633–641.

215.Centanni M, Maiani G, Vermiglio F, et al. Combined impairment of nutritional parameters and thyroid homeostasis in mildly iodine-deficient children. Thyroid 1998;8:155–159.

216.Christian P, West KP Jr. Interactions between zinc and vitamin A: an update. Am J Clin Nutr 1998;68: 435S–441S.

217.Arroyave G, Calcano M. Descendo de los niveles sericos de retinol y su proteina de enlace (RBP) durante las infecciones. Arch Latinoam Nutr 1979;29:233–260.

218.Gerlach TH, Zile MH. Upregulation of serum retinol in experimental acute renal failure. FASEB J 1990;4:2511–2517.

219.Green MH, Green JB, Lewis KC. Variation in retinol utilization rate with the vitamin A status in the rat. J Nutr 1987;117:694–703.

220.Lewis KC, Green MH, Green JB, Zech LA. Retinol metabolism in rats with low vitamin A status: a compartmental model. J Lipid Res 1990;31:1535–1548.

221.Vahlquist A, Peterson PA, Wibell L. Metabolism of the vitamin A-transporting protein complex. I. Turn-over studies in normal persons and in patients with chronic renal failure. Eur J Clin Invest 1973; 3:352–362.

222.Khachik F, Beecher GR, Goli MB, Lusby WR. Separation, identification, and quantification of carotenoids in fruits, vegetables, and human plasma by high performance liquid chromatography. Pure Appl Chem 1991;63:71–80.

223.Khachik F, Beecher GR, Goli MB. Separation and identification of carotenoids and their oxidation products in the extracts of human plasma. Anal Chem 1992;64:2111–2122.

224.Willnow TE, Nykjaer A, Herz J. Lipoprotein receptors: new roles for ancient proteins. Nat Cell Biol 1999;1:E157–E162.

225.Bavik CO, Busch C, Eriksson U. Characterization of a plasma retinol-binding protein membrane receptor expressed in the retinal pigment epithelium. J Biol Chem 1992;267:23035–23042.

226.Kurlandsky SB, Gamble MV, Ramakrishnan R, Blaner WS. Plasma delivery of retinoic acid to tissues in the rat. J Biol Chem 1995;270:17850–17857.

227.Takahashi N, Breitman TR. Retinoylation of proteins in mammalian cells. In: Blomhoff R (ed). Vitamin A in Health and Disease. New York, Marcel Dekker: 1994; pp. 257–273.

228.Myhre AM, Takahashi N, Blomhoff R, Breitman TR, Norum KR. Retinoylation of proteins in rat liver, kidney, and lung in vivo. J Lipid Res 1996;37:1971–1977.

229.Genchi G, Olson JA. Retinoylation of proteins in cell-free fractions of rat tissues in vitro. Biochim Biophys Acta 2001;1530:146–154.

230.Renstrom B, DeLuca HF. Incorporation of retinoic acid into proteins via retinoyl-CoA. Biochim Biophys Acta 1989;998:69–74.

231.Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996;10:940–954.

232.Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 1992;355:446–449.

233.Tran P, Zhang XK, Salbert G, Hermann T, Lehmann JM, Pfahl M. COUP orphan receptors are negative regulators of retinoic acid response pathways. Mol Cell Biol 1992;12:4666–4676.

234.Hirose T, Apfel R, Pfahl M, Jetten AM. The orphan receptor TAK1 acts as a repressor of RAR-, RXRand T3R-mediated signaling pathways. Biochem Biophys Res Commun 1995;211:83–91.

235.Retnakaran R., Flock G, Giguère V. Identification of RVR, a novel orphan nuclear receptor that acts as a negative transcriptional regulator. Mol Endocrinol 1994;8:1234–1244.

236.Carlberg C, van Huijsduijnen RH, Staple JK, DeLamarter JF, Becker-André M. RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol Endocrinol 1994;8:757–770.

237.Ortiz MA, Piedrafita FJ, Pfahl M, Maki R. TOR: a new orphan receptor expressed in the thymus that can modulate retinoid and thyroid hormone signals. Mol Endocrinol 1995;9:1679–1691.

238.Zhao Q, Chasse SA, Devarakonda S, Sierk ML, Ahvazi B, Rastinejad F. Structural basis of RXRDNA interactions. J Mol Biol 2000;296;509–520.

239.Rastinejad F, Wagner T, Zhao Q, Khorasanizadeh S. Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1. EMBO J 2000;19:1045–1054.

240.Rastinejad F. Retinoid X receptor and its partners in the nuclear receptor family. Curr Opin Structural Biol 2001;11:33–38.

241.Buck J, Derguini F, Levi E, Nakanishi K, Hämmerling U. Intracellular signaling by 14-hydroxy-4,14- retro retinol. Science 1991;254:1654–1655.

242.Buck J, Grün F, Kimura S, Noy N, Derguini F, Hämmerling U. Anhydroretinol: a naturally occurring inhibitor of lymphocyte physiology. J Exp Med 1993;178:675.

243.Blumberg B, Bolado J Jr, Derguini F, et al. Novel retinoic acid receptor ligands in Xenopus embryos. Proc Natl Acad Sci USA 1996;93:4873–4878.

244.Nagy L, Thomazy VA, Heyman RA, Davies PJA. Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Dif 1998;5:11–19.

245.Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 2004;328:1–16.

246.Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc: A Report of the Panel on Micronutrients. Washington, D.C., National Academy Press, 2001.

247.World Health Organization. Control of Vitamin A Deficiency and Xerophthalmia: Report of Joint WHO/UNICEF/USAID/Helen Keller International/IVACG Meeting. World Health Organization Technical Report Series No. 672. Geneva: World Health Organization, 1982.

248.Tei M, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Vitamin A deficiency alters the expression of mucin genes by the rat ocular surface epithelium. Invest Ophthalmol Vis Sci 2000;41:82–88.

249.Tseng SCG, Hatchell D, Tierney N, Huang AJW, Sun TT. Expression of specific keratin markers by rabbit corneal, conjunctival, and esophageal epithelia during vitamin A deficiency. J Cell Biol 1984;99: 2279–2286.

250.Sullivan WR, McCulley JP, Dohlman CH. Return of goblet cells after vitamin A therapy in xerosis of the conjunctiva. Am J Ophthalmol 1973;75:720–725.

251.Sommer A, Green WR. Goblet cell response to vitamin A treatment for corneal xerophthalmia. Am J Ophthalmol 1982;94:213–215.

252.Ammon FA von. Beobachtungen, Ansichten und Zweifel über die Entstehung der Xerosis conjunctivae. Zeitschrift für die Ophthalmologie in Verein mit vielen Aerzten 1830–1831;1:65–79.

253.Marchetti L. Intorno la serosi o xerosis della congiuntiva dell’occhio. Effermeridi delle Scienze Mediche 1836;2:50–56.

254.Dupré JMV. Essai sur le xérosis de la conjonctive. Thèse, Faculté de Médecine de Paris, No. 21. Paris, Didot, 1836.

255.Taylor R. Cases of xerophthalmia, with remarks. Edinb Med Surg J 1854;81:21–34.

256.Frugier H. De la xérophthalmie. Thèse, Faculté de Médecine de Paris, No. 242. Paris, Alphonse Derenne, 1880.

257.Semba RD, Wirasasmita S, Natadisastra G, Muhilal, Sommer A. Response of Bitot’s spots in preschool children to vitamin A treatment. Am J Ophthalmol 1990;110:416–420.

258.Sie Boen Lian. Over vlekken van Bitôt, niet behoorend tot het ziektebeeld der xerophthalmie. Geneesk Tijdschr Nederl Indië 1938;78:665–671.

259.Sie-Boen-Lian. Über Bitotsche Flecke, die nicht zu dem Krankheitsbild der Xerophthalmie gehören. Albrecht von Graefe’s Archiv für Ophthalmologie 1938;139:17–21.

260.Leber T. Ueber die Xerosis der Bindehaut und die infantile Hornhautverschwärung nebst Bemerkungen über die Entstehung des Xerophthalmus. Albrecht von Graefe’s Archiv für Ophthalmologie 1883;29:225–290.

261.Weeks JE. Xerosis of the conjunctiva in infants and children. Arch Ophthalmol 1886;15:332–342.

262.Braunschweig P. Zur Kenntniss der infantilen Xerosis conjunctivae. Fortschritte der Medicin 1890; 8:889–900.

263.Basso D. Un’epidemia di emeralopia con xerosi epitheliale della congiuntiva. Annali di Ottalmologia 1897;26:275–305.

264.Mayou MS. The pathological anatomy of the plaques in epithelial xerosis. Trans Ophthalmol Soc UK 1904;24:9–16.

265.Kreiker A. Zur Klinik und Histologie der epithelialen Bindehautxerose. Albrecht von Graefe’s Achiv für Ophthalmologie 1930;124:191–205.

266.Caocci G. Sulla xerosis epiteliale della congiuntiva (contributo clinico e isto-patologico). Arch Ottal 1931;38:528–544.

267.El-Tobgy AF. Histopathology, bacteriology and treatment of Bitot spots. Bull Ophthalmol Soc Egypt 1935;28:79–81.

268.Lijó Pavía J, Irigoyen L, Tartari RA. Xerosis conjuntival. Contribución anátomopatológica. Semana Médica 1938;2:271–277.

269.Argaud R, Berges R. Considérations anatomo-pathologiques sur le xérosis conjonctival (Taches de Bitot). Arch d’Ophtalmol 1938;2:97–107.

270.Damiean-Gillet M. Conjunctival lesions in avitaminosis A. A histopathological study. Trop Geogr Med 1958;10:233–238.

271.Rodger FC, Saiduzzafar H, Grover AD, Fazal A. A reappraisal of the ocular lesion known as Bitot’s spot. Br J Nutr 1963;17:475–485.

272.Reddy PS. Bitot spots and vitamin A deficiencies. Trans Ophthalmol Soc N Zealand 1965;17:90–93.

273.Pfister RR, Renner ME. The corneal and conjunctival surface in vitamin A deficiency: a scanning electron microscope study. Invest Ophthalmol Vis Sci 1978;17:874–883.

274.Ganley JP, Payne CM. Clinical and electron microscopic observations of the conjunctiva of adult patients with Bitot’s spots. Invest Ophthalmol Vis Sci 1981;20:632–643.

275.Sommer A, Green WR, Kenyon KR. Bitot’s spots responsive and nonresponsive to vitamin A. Clinicopathologic correlation. Arch Ophthalmol 1981;99:2014–2027.

276.Meyer E, Miller B, Zonis S. Electron microscope study of Bitot’s spots. Metab Pediatr System Ophthalmol 1987;10:42–44.

277.Lehmann KB, Neumann R. Lehmann’s Medizin, Handatlanten X. Atlas und Grundriss der Bakteriologie und Lehrbuch der speziellen bakteriologischen Diagnostik. 2. Auflage, 1899;2:1–497.

278.Colomiatti P. Notes pour servir à l’étude des ophtalmies parasitaires. Congrès périodique international d’ophthalmologie, Comptes-rendu. Premier Congrès de Milan, 1, 2, 3, et 4 Septembre 1880. Milan, Philippe Poncelletti, 1881, pp. 48–50.

279.Fraenkel E, Franke E. Ueber den Xerosisbacillus und seine ätiologische Bedeutung. Arch Augenheilk 1887;17;176–192.

280.Stephenson S. On epithelial xerosis of the conjunctiva. Trans Ophthalmol Soc UK 1898;18:55–102.

281.Owen HB. The ocular manifestations of vitamin A deficiency. E Afr Med J 1933;10:53–58.

282.Stocker F. Keratitis superficialis und Vitamin A. Schweiz Med Wochenschr 1936;66:335–337.

283.Sommer A, Emran N, Tamba T. Vitamin A-responsive punctate keratopathy in xerophthalmia. Am J Ophthalmol 1979;87:330–333.

284.Newman NJ, Capone A, Leeper HF, et al. Clinical and subclinical ophthalmic findings with retinol deficiency. Ophthalmology 1994;101:1077–1083.

285.Sommer A. Nutritional Blindness: Xerophthalmia and Keratomalacia. New York: Oxford University Press, 1982.

286.Wason IM. Ophthalmia associated with a dietary deficiency in fat soluble vitamin (A). A study of the pathology. J Am Med Assoc 1921;76:908–912.

287.Sheldon H, Zetterqvist H. An electron microscope study of the corneal epithelium in the vitamin A deficient mouse. Bull Johns Hopkins Hosp 1956;98:372–405.

288.Van Horn DL, Schutten WH, Hyndiuk RA, Kurz P. Xerophthalmia in vitamin A-deficient rabbits: clinical and ultrastructural alterations in the cornea. Invest Ophthalmol Vis Sci 1980;19:1067–1079.

289.Kim YCL, Wolf G. Vitamin A deficiency and the glycoproteins of rat corneal epithelium. J Nutr 1974; 104:710–718.

290.Valenton MJ, Tan RV. Secondary ocular bacterial infection in hypovitaminosis A xerophthalmia. Am J Ophthalmol 1975;80:673–677.

291.Sendele DD, Kenyon KR, Wolf G, Hanninen LA. Epithelial abrasion precipitates stromal ulceration in the vitamin A-deficient rat cornea. Invest Ophthalmol Vis Sci 1982;23:64–72.

292.El-Ghorab M, Capone A Jr, Underwood BA, Hatchell D, Friend J, Thoft RA. Response of ocular surface epithelium to corneal wounding in retinol-deficient rabbits. Invest Ophthalmol Vis Sci 1988; 29:1671–1676.

293.Seng WL, Glogowski JA, Wolf G, Berman MB, Kenyon KR, Kiorpes TC. The effect of thermal burns on the release of collagenase from corneas of vitamin A-deficient and control rats. Invest Ophthalmol Vis Sci 1980;19:1461–1470.

294.Seng WL, Kenyon KR, Wolf G. Studies on the source and release of collagenase in thermally burned corneas of vitamin A-deficient and control rats. Invest Ophthalmol Vis Sci 1982;22:62–72.

295.Frangieh GT, Hayashi K, Teekhasaenee C, et al. Fibronectin and corneal epithelial wound healing in the vitamin A-deficient rat. Arch Ophthalmol 1989;107:567–571.

296.Berman M, Leary R, Gage J. Evidence for a role of the plasminogen activator-plasmin system in corneal ulceration. Invest Ophthalmol Vis Sci 1980;19:1204–1221.

297.Hayashi K, Frangieh G, Kenyon KR, Berman M, Wolf G. Plasminogen activator activity in vitamin A-deficient rat corneas. Invest Ophthalmol Vis Sci 1988;29:1810–1819.

298.Hayashi K, Frangieh G, Hanninen LA, Wolf G, Kenyon KR. Stromal degradation in vitamin A- deficient rat cornea. Comparison of epithelial abrasion and stromal incision. Cornea 1990;9:254–265.

299.DeCarlo JD, Van Horn DL, Hyndiuk RA, Davis SD. Increased susceptibility to infection in experimental xerophthalmia. Arch Ophthalmol 1981;99:1614–1617.

300.Twining SS, Zhou X, Schulte DP, Wilson PM, Fish B, Moulder J. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis. Invest Ophthalmol Vis Sci 1996;37:511–522.

301.Kenney MC, Shih LM, Labermeir U, Satterfield D. Modulation of rabbit keratocyte production of collagen, sulfated glycosaminoglycans and fibronectin by retinol and retinoic acid. Biochim Biophys Acta 1986;889:156–162.

302.Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92:827–839.

303.Slansky HH, Freeman MI, Itoi M. Collagenolytic activity in bovine corneal epithlium. Arch Ophthalmol 1968;80:496–498.

304.Itoi M, Gnädinger MC, Slansky HH, Freeman MI, Dohlman CH. Collagenases in the cornea. Exp Eye Res 1969;8:369–373.

305.Pirie A, Werb Z, Burleigh MC. Collagenase and other proteinases in the cornea of the retinol-deficient rat. Br J Nutr 1975;34:297–309.

306.Gordon JM, Bauer EA, Eisen AZ. Collagenase in human cornea. Immunologic localization. Arch Ophthalmol 1980;98:341–345.

307.Twining SS, Schulte DP, Zhou X, Wilson PM, Fish BL, Moulder JE. Changes in rat corneal matrix metalloproteinases and serine proteinases under vitamin A deficiency. Curr Eye Res 1997;16:158–165.

308.Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res 1998;290(suppl):S12–S23.

309.Robertson RB, Ryel RB, Taylor RE, Shyu KW, Fullmer HM. Collagenase: localization in polymorphonuclear leukocyte granules in the rabbit. Science 1972;177:64–65.

310.Alionte LG, Cannon BM, White CD, Caballero AR, O’Callaghan RJ, Hobden JA. Pseudomonas aeruginosa LasA protease and corneal infections. Curr Eye Res 2001;22:266–271.

311.Twining SS, Hatchell DL, Hyndiuk RA, Nassif KF. Acid proteases and histologic correlations in experimental ulceration in vitamin A deficient rabbit corneas. Invest Ophthalmol Vis Sci 1985;26: 31–44.

312.Pan L, Eckhoff C, Brinckerhoff CE. Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. J Cell Biochem 1995;57:575–589.

313.Schüle R, Rangarajan P, Yang N, et al. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc Natl Acad Sci USA 1991;88:6092–6096.

314.Wolf G. The molecular basis of the inhibition of collagenase by vitamin A. Nutr Rev 1992;50:292–294.

315.Schroen DJ, Brinckerhoff CE. Inhibition of rabbit collagenase (matrix metalloproteinase-1; MMP-1) transcription by retinoid receptors: evidence for binding of RARs/RXRs to the -77 AP-1 site through interactions with c-Jun. J Cell Physiol 1996;169:320–332.

316.Shams NBK, Reddy CV, Watanabe K, Elgebaly SA, Hanninen LA, Kenyon KR. Increased interleukin- 1 activity in the injured vitamin A-deficient cornea. Cornea 1994;13:156–166.

317.Lafyatis R, Kim SJ, Angel P, et al. Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5' activator protein-1-binding site. Mol Endocrinol 1990;4:973–980.

318.von Graefe A. Hornhautverschwärung bei infantiler Encephalitis. Albrecht von Graefe’s Archiv für Ophthalmologie 1866;12:250–256.

319.Hirschberg J. Ueber die durch Encephalitis bedingte Hornhautverschwärung bei kleinen Kindern. Berlin Klin Wochenschr 1868;5:324–326.

320.Tiwary R. Intestinal infections and ocular lesions with particular reference to keratomalacia. J All India Ophthalmol Soc 1966;14:87–88.

321.Mukherjee SK, Barat DR. Keratomalacia and intestinal helminthiasis. Indian J Pediatr 1972;39:194–198.

322.Matsuo T, Matsuo N, Shiraga F, Koide N. Keratomalacia in a child with familial hypo-retinol-binding proteinemia. Jpn J Ophthalmol 1988;32:249–254.

323.Feldberg R, Yassur Y, Ben-Sira I, Varsano I, Zelikovitz I. Keratomalacia in acrodermatitis enteropathica (AE). Metab Pediatr Ophthalmol 1981;5:207–211.

324.Hildreth JS. Anästhesie der Cornea mit gleichzeitig verminderter Wirkung des Atropins auf die Iris, und deren Einfluss auf ulcerative Hornhautenzündung. Arch Augenheilk Ohrenheilk 1870;200–202.

325.Elschnig A. Keratomalacie bei Bindehautxerose. Wien Med Wochenschr 1899;49:841–848.

326.Pillat A. Does keratomalacia exist in adults? Arch Ophthalmol 1929;2:256–287, 399–415.

327.Schimmelpfennig W. Über einen Fall von infantiler Conjunctivalxerose mit Keratomalacie. Medicinischen Facultät zu Jena, Dissertation. Leipzig, W. Engelmann, 1896.

328.Smith RS, Farrell T, Bailey T. Keratomalacia. Surv Ophthalmol 1975;20:213–219.

329.Goldschmidt M. Experimenteller Beitrag zur Ätiologie der Keratomalacie. Albrecht von Graefe’s Archiv für Ophthalmol 1915;90:354–366.

330.Valenton MJ. Corneal xerophthalmia and keratomalacia. Arch Ophthalmol 1982;100:1974.

331.Sommer A. Corneal xerophthalmia and keratomalacia—reply. Arch Ophthalmol 1982;100:1974.

332.Yap-Kie-Tiong Y. Protein deficiency in keratomalacia. Br J Ophthalmol 1956;40:502–503.

333.Kuming BS. The evolution of keratomalacia. Tran Ophthalmol Soc UK 1967;87:305–315.

334.Baas KL. Ueber eine Ophthalmia hepatitica. Nebst Beiträgen zur Kenntniss der Xerosis conjunctivae under zur Pathologie der Augenmuskelerkrankungen. Graefe’s Arch Ophthalmol 1894;40:212–246.

335.Purtscher. Beitrag zur Kenntnis der Ophthalmia hepatitica (hepatitica-Baas). Albrecht von Graefe’s Archiv für Ophthalmologie 1900;50:83–122.

336.Mikamo S. [An interesting fundus disease with multiple white dots.] Nippon Ganka Gakkai Zasshi 1915;19:1170–1173.

337.Wright RE. Keratomalacia in southern India. Br J Ophthalmol 1922;6:164–175.

338.Uyemura M. Ueber eine merkwürdige Augenhintergrundveränderung bei zwei Fällen von idiopathischer Hemeralopie. Klin Monatsbl Augenheilk 1928;81:471–473.

339.Fuchs A. White spots of the fundus combained with night blindness and xerosis (Uyemura’s syndrome). Am J Ophthalmol 1959;48:101–103.

340.Fuchs A. Ein Fall von weisspunktiertem Fundus bei Hemeralopie mit Xerose. Klin Monatsbl Augenheilk 1928;81:849–850.

341.Shindo S. Ein seltener Fall der idiopathischen Hemeralopie mit speziellem Hintergrundsbefund. Nippon Ganka Gakkai Zasshi 1930;34:153–154, 1487–1491.

342.Yasutake K. Über einen Fall von Fundus oculi mit zahlreichen gelblichenweissen Punkten bei idiopathischer Hemeralopie. Nippon Ganka Gakkai Zasshi 1933;37:45–46, 540–547.

343.Pillat A. Über einige Augenhintergrundsbefunde bei Nachtblindheit, Präxerose und Xerose. Zeitschr Augenheilk 1933;80:189–192.

344.Pillat A. Die klassichen Symptome des Vitamin A-Mangels und der Vitamin A-Mangel als Gesamterkrunkung des Körpers. Wien Klin Wochenschr 1940;53:779–783.

345.Scullica F. Avitaminosi e syndrome xeroftalmica. Ann Ottal 1935;63:721–772.

346.Ruata V. Oftalmologia dei paesi caldi. Milano, Ulrico Hoepli, 1938.

347.Hollwich. Hemeralopie mit Augenhintergrundsbefund. Klin Monatsbl Augenheilk 1937;98:389–390.

348.Teng-Khoen-Hing. Fundus changes in hypovitaminosis A. Ophthalmologica 1959;137:81–85.

349.Teng Khoen Hing. Fundus xerophthalmicus. Paediatrica Indonesiana 1965a;5:802–811.

350.Teng Khoen Hing. Further contributions to the fundus xerophthalmicus. Ophthalmologica 1965b;150: 219–238.

351.Sommer A, Tjakrasudjatma S, Djunaedi E, Green WR. Vitamin A-responsive panocular xerophthalmia in a healthy adult. Arch Ophthalmol 1978;96:1630–1634.

352.Teng Khoen Hing. Serum vitamin and protein levels in fundus xerophthalmicus. Trop Geogr Med 1965c;17:273–281.

353.Oomen HAPC. Fundus xerophthalmicus. Voeding 1965;26:51–54.

354.Tansley K. Factors affecting the development and regeneration of visual purple in the mammalian retina. Proc Roy Soc Lond B 1933;114:79–103.

355.Tansley K. The effect of vitamin A deficiency on the development of the retina and on the first appearance of visual purple. Biochem J 1936;30:839–844.

356.Johnson ML. The effect of vitamin A deficiency upon the retina of the rat. J Exp Zool 1939;81:67–89.

357.Johnson ML. Degeneration and repair of the rat retina in avitaminosis A. Arch Ophthalmol 1943;29: 793–810.

358.Ramalingaswami V, Leach EH, Sriramachari S. Ocular structure in vitamin A deficiency in the monkey. Q J Exp Physiol 1955;40:337–347.

359.Hayes KC. Retinal degeneration in monkeys induced by deficiencies of vitamin E or A. Invest Ophthalmol 1974;13:499–510.

360.Carter-Dawson L, Kuwabara T, O’Brien PJ, Bieri JG. Structural and biochemical changes in vitamin A-deficient rat retinas. Invest Ophthalmol Vis Sci 1979;18:437–446.

361.Herron WL Jr, Riegel BW. Production rate and removal of rod outer segment material in vitamin A deficiency. Invest Ophthalmol Vis Sci 1974a;13:46–53.

362.Herron WL Jr, Riegel BW. Vitamin A deficiency-induced “rod thinning” to permanently decrease the production of rod outer segment material. Invest Ophthalmol Vis Sci 1974b;13:54–59.

363.Sharman IM. An unusual case of self-imposed vitamin A deficiency. Am J Clin Nutr 1969;22:1134.

364.Fells P, Bors F. Ocular complications of self-induced vitamin A deficiency. Trans Ophthalmol Soc UK 1969;89:221–228.

365.Bors F, Fells P. Reversal of the complications of self-induced vitamin A deficiency. Br J Ophthalmol 1971;55:210–214.

366.Seeliger MW, Biesalski HK, Wissinger B, et al. Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein synthesis. Invest Ophthalmol Vis Sci 1999;40:3–11.

367.Menon K, Vijayaraghavan K. Sequelae of severe xerophthalmia—a follow up study. Am J Clin Nutr 1979;33:218–220.

368.Blackfan KD, Wolbach SB. Vitamin A deficiency in infants. A clinical and pathological study. J Pediatr 1933;3:679–706.

369.Sweet LK, K’ang HJ. Clinical and anatomic study of avitaminosis A among the Chinese. Am J Dis Child 1935;50:699–734.

370.McLaren DS. Malnutrition and the Eye. New York, Academic Press, 1963.

371.Koo JS, Jetten AM, Belloni P, et al. Role of retinoid receptors in the regulation of mucin gene expression by retinoic acid in human tracheobronchial epithelial cells. Biochem J 1999;338:351–357.

372.Gijbels MJJ, van der Harn F, van Bennekum AM, Hendriks HF, Roholl RJ. Alterations in cytokeratin expression precede histological changes in epithelia of vitamin A-deficient rats. Cell Tissue Res 1992; 268:197–203.

373.Darwiche N, Celli G, Sly L, Lancillotti F, DeLuca LM. Retinoid status controls the appearance of reserve cells and keratin expression in mouse cervical epithelium. Cancer Res 1993;53(suppl 20):2287– 2299.

374.Van Agtmaal EJ. Vitamin A and Protein in Tear Fluid: A Nutritional Field Survey on Preschool Children in Northeast Thailand [thesis]. Amsterdam, University of Amsterdam, 1989.

375.Nauss KM, Anderson CA, Conner MW, Newberne PM. Ocular infection with herpes simplex virus (HSV-1) in vitamin A-deficient and control rats. J Nutr 1985;115:1300–1315.

376.Shams NB, Hanninen LA, Chaves HV, et al. Effect of vitamin A deficiency on the adhesion of rat corneal epithelium and the basement membrane complex. Invest Ophthalmol Vis Sci 1993;34:2646– 2654.

377.Wilhelm DL. Regeneration of the tracheal epithelium in the vitamin-A-deficient rat. J Pathol Bact 1954; 67:361–365.

378.Wong YC, Buck RC. An electron microscopic study of metaplasia of the rat tracheal epithelium in vitamin A deficiency. Lab Invest 1971;24:55–66.

379.McDowell EM, Keenan KP, Huang M. Effects of vitamin A-deprivation on hamster tracheal epithelium: a quantitative morphologic study. Virchows Arch B 1984;45:197–219.

380.Fuchs E, Green H. Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell 1981;25:617–625.

381.Eckert Rl, Green H. Cloning of cDNAs specifying vitamin A-responsive human keratins. Proc Natl Acad Sci USA 1984;81:4321–4325.

382.Manna B, Lund M, Ashbaugh P, Kaufman B, Bhattacharyya SN. Effect of retinoic acid on mucin gene expression in rat airways in vitro. Biochem J 1994;297:309–313.

383.Manna B, Ashbaugh P, Bhattacharyya SN. Retinoic-acid regulated cellular differentiation and mucin gene expression in isolated rabbit tracheal epithelial cells in culture. Inflammation 1995;19:489–502.

384.Paquette NC, Zhang LY, Ellis WA, Scott AL, Kleeberger SR. Vitamin A deficiency enhances ozoneinduced lung injury. Am J Physiol 1996;270:L475–L482.

385.Rojanapo W, Lamb AJ, Olson JA. The prevalence, metabolism and migration of goblet cells in rat intestine following the induction of rapid. synchronous vitamin A deficiency. J Nutr 1980;110:178–180.

386.Puengtomwatanakul S, Sirisinha S. Impaired biliary secretion of immunoglobulin A in vitamin A- deficient rats. Proc Soc Exp Biol Med 1986;182:437–442.

387.Warden RA, Strazzari MJ, Dunkley PR, O’Loughlin EV. Vitamin A-deficient rats have only mild changes in jejunal structure and function. J Nutr 1996;126:1817–1826.

388.Ahmed F, Jones DB, Jackson AA. The interaction of vitamin A deficiency and rotavirus infection in the mouse. Br J Nutr 1990;63:363–373.

389.Molloy CL, Laskin JD. Effect of retinoid deficiency on keratin expression in mouse bladder. Exp Mol Pathol 1988;49:128–140.

390.Brown KH, Gaffar A, Alamgir SM. Xerophthalmia, protein-calorie malnutrition, and infections in children. J Pediatr 1979;95:651–656.

391.Rombout JH, Sijtsma SR, West CE, et al. Effect of vitamin A deficiency and Newcastle disease virus infection on IgA and IgM secretion in chickens. Br J Nutr 1992;68:753–763.

392.Gangopadhyay NN, Moldoveanu Z, Stephensen CB. Vitamin A deficiency has different effects on immunoglobulin A production and transport during influenza A infection in BALB/c mice. J Nutr 1996; 126:2960–2967.

393.Ahmed F, Jones DB, Jackson AA. Effect of vitamin A deficiency on the immune response to epizootic diarrhoea of infant mice (EDIM) rotavirus infection in mice. Br J Nutr 1991;65:475–485.

394.Wiedermann U, Hanson LÅ, Holmgren J, Kahu H, Dahlgren UI. Impaired mucosal antibody response to cholera toxin in vitamin A-deficient rats immunized with oral cholera vaccine. Infect Immun 1993; 61:3952–3957.

395.Nikawa T, Odahara K, Koizumi H, et al. Vitamin A prevents the decline in immunoglobulin A and Th2 cytokine levels in small intestinal mucosa of protein-malnourished mice. J Nutr 1999;129:934–941.

396.Nikawa T, Ikemoto M, Kano M, et al. Impaired vitamin A-mediated mucosal IgA response in IL-5 receptor-knockout mice. Biochem Biophys Res Commun 2001;285:546–549.

397.Sarkar J, Gangopadhyay NN, Moldoveanu Z, Mestecky J, Stephensen CB. Vitamin A is required for regulation of polymeric immunoglobulin receptor (pIgR) expression by interleukin-4 and interferon-γ in a human intestinal epithelial cell line. J Nutr 1998;128:1063–1069.

398.Thurnham DI, Northrup-Clewes CA, McCullough FS, Das BS, Lunn PG. Innate immunity, gut integrity, and vitamin A in Gambian and Indian infants. J Infect Dis 2000;182(suppl 1):S23–S28.

399.Okada M, Bothin C, Blomhoff R, Kanazawa K, Midtvedt T. Vitamin A deficiency impairs colonic healing but not adhesion formation in germ-free and conventional rats. J Invest Surg 1999;12:319–325.

400.Nauss KM, Newberne PM. Local and regional immune function of vitamin A-deficient rats with ocular herpes simplex virus (HSV) infections. J Nutr 1985;115:1316–1324.

401.Bowman TA, Goonewardene IM, Pasatiempo AMG, Ross AC. Vitamin A deficiency decreases natural killer cell activity and interferon production in rats. J Nutr 1990;120:1264–1273.

402.Zhao Z, Murasko DM, Ross AC. The role of vitamin A in natural killer cell cytotoxicity, number and activation in the rat. Natural Immunity 1994;13:29–41.

403.Dawson HD, Li NQ, DeCicco KL, Nibert JA, Ross AC. Chronic marginal vitamin A status reduces natural killer cell number and function in aging Lewis rats. J Nutr 1999;129:1510–1517.

404.Hussey G, Hughes J, Potgieter S, et al. Vitamin A status and supplementation and its effects on immunity in children with AIDS. XVII International Vitamin A Consultative Group Meeting. Virtual Elimination of Vitamin A Deficiency: Obstacles and Solutions for the Year 2000, 18–22 March 1996, Guatemala [abstracts]. International Life Sciences Institute, Washington, D.C., 1996, p. 6.

405.Lawson ND, Berliner N. Neutrophil maturation and the role of retinoic acid. Exp Hematol 1999;27: 1355–1367.

406.Ongsakul M, Sirisinha S, Lamb A. Impaired blood clearance of bacteria and phagocytic activity in vitamin A-deficient rats. Proc Soc Exp Biol Med 1985;178:204–208.

407.Twining SS, Schulte DP, Wilson PM, Fish BL, Moulder JE. Vitamin A deficiency alters rat neutrophil function. J Nutr 1996;127:558–565.

408.Wiedermann U, Tarkowski A, Bremell T, Hanson LÅ, Kahu H, Dahlgren UI. Vitamin A deficiency predisposes to Staphylococcus aureus infection. Infect Immun 1996;64:209–214.

409.Higuchi H, Nagahata H. Effects of vitamins A and E on superoxide production and intracellular signaling of neutrophils in Holstein calves. Can J Vet Res 2000;64:69–75.

410.Zhao Z, Ross AC. Retinoic acid repletion restores the number of leukocytes and their subsets and stimulates natural cytotoxicity in vitamin A-deficient rats. J Nutr 1995;125:2064–2073.

411.Kuwata T, Wang IM, Tamura T, et al. Vitamin A defciency in mice causes a systemic expansion of myeloid cells. Blood 2000;95:3349–3356.

412.Torii A, Miyake M, Morishita M, Ito K, Torii S, Sakamoto T. Vitamin A reduces lung granulomatous inflammation with eosinophilic and neutrophilic infiltration in Sephadex-treated rats. Eur J Pharmacol 2004;487:335–342.

413.Semba RD, Muhilal, Ward BJ, et al. Abnormal T-cell subset proportions in vitamin A-deficient children. Lancet 1993;341:5–8.

414.Benn CS, Lisse IM, Bale C, et al. No strong long-term effect of vitamin A supplementation in infancy on CD4 and CD8 T-cell subsets. A community study from Guinea-Bissau, West Africa. Ann Trop Paediatr 2000;20:259–264.

415.Van Schravendijk MR, Handunnetti SM, Barnwell JW, Howard RJ. Normal human erythrocytes express CD36, an adhesion molecule of monocytes, platelets, and endothelial cells. Blood 1992;80: 2105–2114.

416.Perrin MC, Blanchet JP, Mouchiroud G. Modulation of human and mouse erythropoiesis by thyroid hormone and retinoic acid: evidence for specific effects at different steps of the erythroid pathway. Hematol Cell Therapy 1997;39:19–26.

417.Zermati Y, Fichelson S, Valensi F, et al. Transforming growth factor inhibits erythropoiesis by blocking proliferation of accelerating differentiation of erythroid progenitors. Exp Hematol 2000;28:885–894.

418.Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980;77:2936–2940.

419.Öberg F, Botling J, Nilsson K. Functional antagonism between vitamin D3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells. J Immunol

1993;150:3487–3495.

420.Hemmi H, Breitman TR. Induction of functional differentiation of human monocytic leukemia cell line (THP-1) by retinoic acid and cholera toxin. Jpn J Canc Res 1985;76:345–351.

421.Katz DR, Drzymala M, Turton JA, et al. Regulation of accessory cell function by retinoids in murine immune responses. Brit J Exp Pathol 1987;68:343–350.

422.Katz DR, Mukherjee S, Malsey J, et al. Vitamin A acetate as a regulator of accessory cell function in delayed-type hypersensitivity responses. Int Arch Allergy Appl Immunol 1987;82:53–56.

423.Smith SM, Levy NS, Hayes CE. Impaired immunity in vitamin A-deficient mice. J Nutr 1987;117: 857–865.

424.Mathew JS, Sharma RP. Effect of all-trans-retinoic acid on cytokine production in a murine macrophage cell line. Int J Immunopharm 2000;22:693–706.

425.Matikainen S, Serkkola E, Hurme M. Retinoic acid enhances IL-1β expression in myeloid leukemia cells and in human monocytes. J Immunol 1991;147:162–167.

426.Hashimoto S, Hayashi S, Yoshida S, et al. Retinoic acid differentially regulates interleukin-1β and interleukin-1 receptor antagonist production by human alveolar macrophages. Leukemia Res 1998;22: 1057–1061.

427.Na SY, Kang BY, Chung SW, et al. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFκB. J Biol Chem 1999;274:7674–7680.

428.Dillehay DL, Walla AS, Lamon EW. Effects of retinoids on macrophage function and IL-1 activity. J Leuk Biol 1988;44:353–360.

429.Trechsel U, Evêquoz V, Fleisch H. Stimulation of interleukin 1 and 3 production by retinoid acid in vitro. Biochem J 1985;230:339–344.

430.Hatchigian EA, Santos JI, Broitman SA, Vitale JJ. Vitamin A supplementation improves macrophage function and bacterial clearance during experimental Salmonella infection. Proc Soc Exp Biol Med 1989;191:47–54.

431.Maisey J, Miller K. Assessment of the ability of mice fed on vitamin A supplemented diet to respond to a variety of potential contact sensitizers. Contact Dermatitis 1986;15:17–23.

432.Sailstad DM, Krishnan SD, Tepper JS, Doerfler DL, Selgrade MK. Dietary vitamin A enhances sensitivity of the local lymph node assay. Toxicology 1995;96:157–163.

433.Meunier L, Bohjanen K, Voorhees JJ, et al. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a β2 integrin integrally involved in T-

cell activation. J Invest Dermatol 1994;103:775–779.

434.Göttgens B, Green AR. Retinoic acid and the differentiation of lymphohaemapoietic stem cells. BioAssays 1995;17:187–189.

435.Garbe A, Buck J, Hämmerling U. Retinoids are important cofactors in T cell activation. J Exp Med 1992;176:109–117.

436.Allende LM, Corell A, Madrono A, et al. Retinol (vitamin A) is a cofactor in CD3-induced human T-lymphocyte activation. Immunology 1997;90:388–396.

437.Friedman A, Halevy O, Schrift M, et al. Retinoic acid promotes proliferation and induces expression of retinoic acid receptor-α gene in murine T lymphocytes. Cell Immunol 1993;152:240–248.

438.Sidell N, Chang B, Bhatti L. Upregulation by retinoic acid of interleukin-2-receptor mRNA in human T lymphocytes. Cell Immunol 1993;146:28–37.

439.Rahman MM, Mahalanabis D, Alvarez JO, et al. Effect of early vitamin A supplementation on cellmediated immunity in infants younger than 6 mo. Am J Clin Nutr 1997;65:144–148.

440.Stephensen CB. Vitamin A, infection, and immune function. Annu Rev Nutr 2001;21:167–192.

441.Carman JA, Pond L, Nashold F, Wassom DL, Hayes CE. Immunity to Trichinella spiralis infection in vitamin A-deficient mice. J Exp Med 1992;175:111–120.

442.Cantorna MT, Nashold FE, Hayes CE. In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J Immunol 1994;152: 1515–1522.

443.Cantorna MT, Nashold FE, Hayes CE. Vitamin A deficiency results in a priming environment conducive for Th1 cell development. Eur J Immunol 1995;25:1673–1679.

444.Wiedermann U, Hanson LA, Kahu H, Dahlgren UI. Aberrant T-cell function in vitro and impaired T-cell dependent antibody response in vivo in vitamin A-deficient rats. Immunology 1993;80:581– 586.

445.Frankenburg S, Wang X, Milner Y. Vitamin A inhibits cytokines produced by type 1 lymphocytes in vitro. Cell Immunol 1998;185:75–81.

446.Cui D, Moldoveanu Z, Stephensen CB. High-level dietary vitamin A enhances T-helper type 2 cytokine production and secretory immunoglobulin A response to influenza A virus infection in BALB/c mice. J Nutr 2000;130:1322–1329.

447.Stephensen CB, Rasoly R, Jiang X, et al. Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway. J Immunol 2002;168:4495–4503.

448.Carman JA, Hayes CE. Abnormal regulation of IFN-γ secretion in vitamin A deficiency. J Immunol 1991;147:1247–1252.

449.Cantorna MT, Nashold FE, Chun TY, Hayes CE. Vitamin A down-regulation of IFN-γ synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway. J Immunol 1996;156: 2674–2679.

450.Cippitelli M, Ye J, Viggiano V, et al. Retinoic acid-induced transcriptional modulation of the human interferon-gamma promoter. J Biol Chem 1996;271:26783–26793.

451.Stephensen CB, Jiang X, Freytag T. Vitamin A deficiency increases the in vivo development of IL-10 positive Th2 cells and decreases development of Th1 cells in mice. J Nutr 2004;134:2660– 2666.

452.Buck J, Ritter G, Dannecker L, et al. Retinol is essential for growth of activated human B cells. J Exp Med 1990;171:1613–1624.

453.Blomhoff HK, Smeland EB, Erikstein B, et al. Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells. J Biol Chem 1992;267:23988–23992.

454.Buck J, Myc A, Garbe A, Cathomas G. Differences in the action and metabolism between retinol and retinoic acid in B lymphocytes. J Cell Biol 1991;115:851–859.

455.Israel H, Odziemiec C, Ballow M. The effects of retinoic acid on immunoglobulin synthesis by human cord blood mononuclear cells. Clin Immunol Immunopathol 1991;59:417–425.

456.Wang W, Ballow M. The effects of retinoic acid on in vitro immunoglobulin synthesis by cord blood and adult peripheral blood mononuclear cells. Cell Immunol 1993;148:291–300.

457.Wang W, Napoli JL, Ballow M. The effects of retinol on in vitro immunoglobulin synthesis by cord blood and adult peripheral blood mononuclear cells. Clin Exp Immunol 1993;92:164–168.

458.Ballow M, Wang W, Xiang S. Modulation of B-cell immunoglobulin synthesis by retinoic acid. Clin Immunol Immunopathol 1996;80:S73–S81.

459.Lømo J, Smeland EB, Ulven S, et al. RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes. J Cell Physiol 1998;175:68–77.